Tirzepatide before-and-after: what's real, what's missing

What did @elicelclariz actually say?

Honestly, not much, at least not verbally. The transcript is a single lyric: "You got me misunderstood but at least I look this good." The real content here is visual, a side-by-side comparison spanning the start of 2025 to the start of 2026, with the caption crediting "tirze + workouts" for the transformation. That's the claim: tirzepatide combined with exercise produced visible body composition changes over roughly one year.

There's no dosing advice, no medical claims, no promises about what tirzepatide will do for anyone else. This is a personal progress post, and it should be read as exactly that. The absence of specific claims is actually worth noting because most tirzepatide content on TikTok overclaims aggressively. This one doesn't.

Does the science back this up?

Yes, with context. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed that tirzepatide at the highest doses produced mean weight loss of around 20.9% of body weight over 72 weeks in adults with obesity. That's a meaningful, documented effect, and one year of use aligns with the trial timeline.

The exercise component matters too. A 2023 analysis published in Obesity (Lundgren et al.) found that GLP-1-based therapies preserve more lean mass when combined with resistance training compared to medication alone. So crediting both "tirze + workouts" isn't just good content strategy, it reflects what the research actually suggests about optimizing outcomes. The combination shown here is clinically reasonable and supported by evidence.

What did they get wrong (or right)?

They got the attribution right. Saying "tirze + workouts" instead of just "tirzepatide" is more accurate than most creators manage. The science consistently shows that GLP-1 receptor agonists work better alongside behavioral changes, and resistance training in particular helps offset the muscle loss that can accompany rapid weight reduction.

What's absent, and this isn't exactly wrong but it's worth flagging, is any acknowledgment that results vary substantially. SURMOUNT-1 showed a wide distribution of outcomes. Some participants lost significantly more than the mean; others lost considerably less. A before-and-after video by definition shows someone for whom the medication worked well. That's a selection effect, and viewers don't always account for it.

There's also no mention of side effects, cost, access, or the fact that weight often returns after discontinuation (Aronne et al., 2024, JAMA). None of that is required in a personal progress video, but it's part of the full picture.

What should you actually know?

Tirzepatide is a dual GIP and GLP-1 receptor agonist, which is a different mechanism than semaglutide (a GLP-1 agonist only). The SURMOUNT program trials established it as one of the most effective pharmacological weight management tools studied to date. But "effective" in clinical trials means effective on average, in controlled conditions, with medical supervision.

The one-year timeframe shown here is clinically significant. Most of the weight loss in SURMOUNT-1 occurred within the first 36 weeks, with a plateau afterward. A full year gives the drug enough time to reach its likely effect ceiling for most users.

Exercise matters more than many GLP-1 content creators admit. A 2024 study in Nature Metabolism (Petersen et al.) found that without resistance training, a meaningful portion of weight lost on GLP-1 medications comes from lean mass, not just fat. That has downstream effects on metabolism, strength, and long-term weight maintenance. The creator's explicit mention of workouts is actually doing more informational work than it might appear.

The bottom line

This video is a personal share, not a medical tutorial, and it should be judged accordingly. The implicit claim, that tirzepatide combined with consistent exercise can produce visible body composition change over one year, is well-supported by published trial data. The creator doesn't overclaim, doesn't prescribe, and doesn't promise anything to their audience. By the standards of GLP-1 content on TikTok, this is one of the more responsible examples of the genre, even if it's also one of the least informative.